Mediplantex National Pharmaceutical JSC (HNX:MED)
22,800
0.00 (0.00%)
At close: Sep 19, 2025
HNX:MED Revenue
Mediplantex National Pharmaceutical JSC had revenue of 86.90B VND in the quarter ending June 30, 2025, a decrease of -37.94%. This brings the company's revenue in the last twelve months to 360.49B, down -22.34% year-over-year. In the year 2024, Mediplantex National Pharmaceutical JSC had annual revenue of 443.14B with 10.03% growth.
Revenue (ttm)
360.49B
Revenue Growth
-22.34%
P/S Ratio
0.78
Revenue / Employee
1.10B
Employees
328
Market Cap
282.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 443.14B | 40.39B | 10.03% |
Jan 1, 2024 | 402.74B | 1.69B | 0.42% |
Dec 31, 2022 | 401.05B | 57.10B | 16.60% |
Dec 31, 2021 | 343.95B | -177.44B | -34.03% |
Dec 31, 2020 | 521.39B | -207.08B | -28.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition